Request for Covid-19 Impact Assessment of this Report
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
HeyReport estimates that the Flu Vaccine market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.
In this report, HeyReport discusses the Global & China industrial policies, economic environment, and the impact of covid-19 on the Flu Vaccineindustry and its cost structure. Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.
Market Segment as follows:
Product Type Segmentation Includes
Fluzone/Vaxigrip
Anflu
FluMist
Fluarix
FluLaval
Fluvax/Afluria
Fluvirin
Others
Application Segmentation Includes
Pediatrics
Adults
Companies Includes
AstraZeneca
CSL Limited
GSK
Hualun Biologicalsamong
ID Biomedical Corporation
Johnson & Johnson
MedImmune, LLC
Mylan
Novartis
Pfizer
Protein Sciences Corporaton
Sanofi Pasteur
Serum Institute of India
Sinovac Biotech
The main contents of the report including:
Section 1:
Product definition, type and application, Global & China market overview;
Section 2:
Global & China Market competition by company;
Section 3:
Global & China sales revenue, volume and price by Ofvaccines;
Section 4:
Global & China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
Industrial policies & economic environment
Section 9:
Conclusion.
For any other requirements, please feel free to contact HeyReport for customized contents.
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Ofvaccines
1.1.2.1 Fluzone/Vaxigrip
1.1.2.2 Anflu
1.1.2.3 FluMist
1.1.2.4 Fluarix
1.1.2.5 FluLaval
1.1.2.6 Fluvax/Afluria
1.1.2.7 Fluvirin
1.1.2.8 Others
1.1.3 Market by Application
1.1.3.1 Pediatrics
1.1.3.2 Adults
1.2 Global & China Market Size & Forecast
1.2.1 Global Market (2015-2020 & 2021-2026)
1.2.2 China Market (2015-2020 & 2021-2026)
2 Global & China Market by Company
2.1 Global Sales by Company
2.2 China Sales by Company
3 Global & China Market by Ofvaccines
3.1 Global Sales by Product Type
3.2 China Sales by Product Type
4 Global & China Market by Application
4.1 Global Sales by Application
4.2 China Sales by Application
5 China Trade
5.1 Export Overview
5.2 Import Overview
6 Key Companies List
6.1 AstraZeneca
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.2 CSL Limited
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 GSK
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Hualun Biologicalsamong
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 ID Biomedical Corporation
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Johnson & Johnson
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 MedImmune, LLC
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Mylan
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Novartis
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 Pfizer
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Protein Sciences Corporaton
6.11.1 Company Information
6.11.2 Product Specifications
6.11.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.12 Sanofi Pasteur
6.12.1 Company Information
6.12.2 Product Specifications
6.12.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
6.13 Serum Institute of India
6.13.1 Company Information
6.13.2 Product Specifications
6.13.3 Business Data (2015-2020) (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.14 Sinovac Biotech
6.14.1 Company Information
6.14.2 Product Specifications
6.14.3 Business Data (2015-2020) ( Sales Revenue, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Upstream Overview
8 Policies & Market Environment
8.1 Policies
8.1.1 Major Regions Policies
8.1.2 Policies in China
8.2 Market Environment
8.2.1 Porter's Five Forces
8.2.2 Impact of COVID-19
9 Research Conclusion
Table Global Market Sales Revenue by Company 2015-2020
Table Global Market Sales Revenue Share by Company 2015-2020
Table Global Market Sales Volume by Company 2015-2020
Table Global Market Sales Volume Share by Company 2015-2020
Table Global Price by Company 2015-2020
Table China Market Sales Revenue by Company 2015-2020
Table China Market Sales Revenue Share by Company 2015-2020
Table China Market Sales Volume by Company 2015-2020
Table China Market Sales Volume Share by Company 2015-2020
Table China Price by Company 2015-2020
Table Global Market Sales Revenue by Ofvaccines 2015-2020
Table Global Market Sales Revenue Share by Ofvaccines 2015-2020
Table Global Market Sales Volume by Ofvaccines 2015-2020
Table Global Market Sales Volume Share by Ofvaccines 2015-2020
Table Global Price by Ofvaccines 2015-2020
Table China Market Sales Revenue by Ofvaccines 2015-2020
Table China Market Sales Revenue Share by Ofvaccines 2015-2020
Table China Market Sales Volume by Ofvaccines 2015-2020
Table China Market Sales Volume Share by Ofvaccines 2015-2020
Table China Price by Ofvaccines 2015-2020
Table Global Market Sales Revenue by Application 2015-2020
Table Global Market Sales Revenue Share by Application 2015-2020
Table Global Market Sales Volume by Application 2015-2020
Table Global Market Sales Volume Share by Application 2015-2020
Table Global Price by Application 2015-2020
Table China Market Sales Revenue by Application 2015-2020
Table China Market Sales Revenue Share by Application 2015-2020
Table China Market Sales Volume by Application 2015-2020
Table China Market Sales Volume Share by Application 2015-2020
Table China Price by Application 2015-2020
Table China Export 2015-2020 (Million USD)
Table China Export 2015-2020 ()
Table China Import 2015-2020 (Million USD)
Table China Import 2015-2020 ()
Table Sales Revenue, Cost and Margin of AstraZeneca
Table Sales Revenue, Cost and Margin of CSL Limited
Table Sales Revenue, Cost and Margin of GSK
Table Sales Revenue, Cost and Margin of Hualun Biologicalsamong
Table Sales Revenue, Cost and Margin of ID Biomedical Corporation
Table Sales Revenue, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Cost and Margin of MedImmune, LLC
Table Sales Revenue, Cost and Margin of Mylan
Table Sales Revenue, Cost and Margin of Novartis
Table Sales Revenue, Cost and Margin of Pfizer
Table Sales Revenue, Cost and Margin of Protein Sciences Corporaton
Table Sales Revenue, Cost and Margin of Sanofi Pasteur
Table Sales Revenue, Cost and Margin of Serum Institute of India
Table Sales Revenue, Cost and Margin of Sinovac Biotech
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...